首页> 外文期刊>Trials >Efficacy of a midwife-coordinated, individualized, and specialized maternity care intervention (ChroPreg) in addition to standard care in pregnant women with chronic disease: protocol for a parallel randomized controlled trial
【24h】

Efficacy of a midwife-coordinated, individualized, and specialized maternity care intervention (ChroPreg) in addition to standard care in pregnant women with chronic disease: protocol for a parallel randomized controlled trial

机译:助产士协调,个体化和专门的产妇护理干预措施(ChroPreg)以及慢性病孕妇的标准护理效果:一项平行随机对照试验的方案

获取原文
       

摘要

The number of women of childbearing age with chronic diseases is rising. Evidence has shown that obstetric complications and poor psychological well-being are more prevalent among this group, in addition to these women reporting experiences of less than satisfactory care. More research is needed to investigate how to best meet the special needs of this group during pregnancy and postpartum. Previous research has shown that care coordination, continuity of care, woman-centered care, and specialized maternity care interventions delivered to women with high-risk pregnancies can improve patient-reported outcomes and pregnancy outcomes and be cost-effective. However, no previous trials have examined the efficacy and cost-effectiveness of such interventions among pregnant women with chronic diseases. This paper describes the protocol of a randomized controlled trial (RCT) of a midwife-coordinated, individualized and specialized maternity care intervention (ChroPreg) as an add-on to standard care for pregnant women with chronic diseases. This two-arm parallel group RCT will be conducted from October 2018 through June 2020 at the Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, Denmark. Pregnant women with chronic diseases are invited to participate; women will be randomized and allocated 1:1 to the ChroPreg intervention plus standard care or standard care alone. The ChroPreg intervention consists of three main components: (1) coordinated and individualized care, (2) additional ante- and postpartum consultations, and (3) specialized midwives. The primary outcome is length of hospital stay during pregnancy and in the postpartum period, and secondary outcomes are psychological well-being (five-item World Health Organization Well-Being Index, Edinburgh Postnatal Depression Scale, Cambridge Worry Scale), health-related quality of life (12-Item Short Form Health Survey), patient satisfaction (Pregnancy and Childbirth Questionnaire), number of antenatal contacts, and pregnancy and delivery outcomes. Data are collected via patient-administered questionnaires and medical records. This trial is anticipated to contribute to the field of knowledge on which planning of improved antenatal, intra-, and postpartum care for women with chronic disease is founded. ClinicalTrials.gov, NCT03511508 . Registered April 27, 2018.
机译:育有慢性疾病的育龄妇女的人数正在增加。证据表明,除了这些妇女报告的护理经验不足外,该组中的产科并发症和心理健康状况较差更为普遍。需要更多的研究来研究如何最好地满足该组在怀孕和产后的特殊需求。先前的研究表明,向高风险孕妇提供的护理协调,护理的连续性,以妇女为中心的护理以及专门的产妇护理干预措施可以改善患者报告的结局和妊娠结局,并且具有成本效益。但是,以前没有试验研究过这种干预措施在患有慢性疾病的孕妇中的功效和成本效益。本文介绍了一项助产士协调的,个性化的和专门的产妇护理干预措施(ChroPreg)的随机对照试验(RCT)方案,该方案是对慢性病孕妇的标准护理的补充。这项由两组人组成的平行小组RCT将于2018年10月至2020年6月在丹麦Rigshospitalet哥本哈根大学医院的妇产科进行。邀请患有慢性疾病的孕妇参加;女性将被随机分配并按1:1比例分配给ChroPreg干预,标准护理或仅标准护理。 ChroPreg干预措施包括三个主要部分:(1)协调和个性化的护理,(2)产前和产后的额外咨询,以及(3)专业的助产士。主要结局是怀孕期间和产后的住院时间,次要结局是心理健康(世界卫生组织的五项幸福指数,爱丁堡产后抑郁量表,剑桥忧虑量表),与健康相关的质量生活(12项简短健康调查),患者满意度(怀孕和分娩问卷),产前接触次数以及妊娠和分娩结局。通过患者管理的问卷和病历收集数据。预计该试验将有助于知识领域,从而为慢性病妇女制定改善产前,产后和产后护理的计划。 ClinicalTrials.gov,NCT03511508。 2018年4月27日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号